Interactions with cardiovascular drugs.
Opie
L H
LH
University of Cape Town, Ischemic Heart Disease Research Unit, South Africa.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000494:pharmacology*; D004232:Diuretics / Q000494:pharmacology; D004347:Drug Interactions; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D001798:Blood Proteins; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D004232:Diuretics; D005343:Fibrinolytic Agents; D014665:Vasodilator Agents